DOCSLIB.ORG

Occupational Medicine Symposia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Occupational Medicine Symposia OCCUPATIONAL MEDICINE SYMPOSIA U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Center for Disease Control National Institute for Occupational Safety and Health Division of Occupational Health Programs ----- - . Rockville,. ·-- --r---�--Maryland May 1975 This publication contains major papers presented at the 34th American Medical Association Congress on Occupational Health, held September 9 to 10, 1974 in Chicago, Illinois. The Congress was supported in part by the National Institute for Occupational Safety and Health through Contract No. CDC-99-74-30. Dr. Henry Howe was AMA Project Director and compiled the initial proceedings from the verbatim transcript. The assistance of the following individuals is gratefully acknowledged: Ernest B. Howard, M.D. William R. Barclay, M.D. Asher J. Finkel, M.D. Henry F. Howe, M.D. CDC-NIOSH David J. Sencer, M.D. Marcus M. Key, M.D. Raymond T. ~oore, M.D. A. Walter Hoover, M.D. Leo A. Sanders Marilyn K. Hutchison, M.D. HEW Publication No. (NIOSH) 75-189 FOREWORD A primary goal of the National Institute for Occupational Safety and Health is to promote effective health care for American working men and women. Since the passage of the Occupational Safety and Health Act of 1970, a growing number of family practitioners and internists have entered the part-time practice of occupational medicine. Helping these physicians to incorporate the concepts and skills of occupational medical practice into the total delivery of health services is a major consideration of the Institute's Division of Occupational Health Programs. Toward this end, NIOSH co-sponsored the AMA's 34th Annual Congress on Occupational Health and cooperated in developing the scientific program for the Congress. The seven symposia of the Congress were presented by prominent and eminently qualified speakers from a variety of medical specialties, industrial hygiene, and engineering. The program was a unique and comprehensive review of selected areas of occupational medical practice. NIOSH is publishing the major papers presented at the Congress in this text in order to bring the benefits of this unusual program to as many individuals in the field as possible. if ~ I{) J John F. Finklea, M.D. Director, National Institute for Occupational Safety and Health PREFACE The enthusiastic response of participants to the program presented at the AMA 34th Annual Congress on Occupational Health, co-sponsored by the National Institute for Occupational Safety and Health, led to NIOSH's publication of these symposia. It is hoped that this reference text will stimulate the interest of physicians in the particular opportunities and problems of occupational medical practice, as well as meet the needs of the growing number of physicians who find occupational health considerations now a part of their practice. The manuscript was prepared from verbatim transcripts of the Congress proceedings. Papers are published essentially as presented. However, they were edited by NIOSH for written presentation and titles were assigned to facilitate the use of the publication. Also, an Editor's note has been inserted· to introduce the papers in Symposium II and to clarify references made by the speakers to NIOSH Programs. Except for NIOSH speakers, the papers do not necessarily represent the views of NIOSH but are presented as an introduction to the practice and controversies of occupational medicine. The Congress also included 1ive1y'and informative question and answer sessions. However, it was not possible to transcribe these sessions in this text due to their length and informality. The Division of Occupational Health Programs has a limited number of transcripts of this part of the Congress and will send individual copies on request while supplies last. Marilyn K. Hutchison, M.D. Acting Director, Division of Occupational Health Programs TABLE OF CONTENTS PAGE FOREWORD iii PREFACE v ABSTRACT vii INTRODUCTION vii OCCUPATIONAL PULMONARY DISEASES Hypersensitivity Pneumonitis, Howard A. Buechner, M.D. I-I Silicosis, Howard S. VanOrstrand, M.D. 1-8 VIEWBOX CHEST X-RAY DEMONSTRATION, OCCUPATIONAL PULMONARY DISEASES ly American College of Radiology Radiological Changes In Pneumoconiosis, Including Coal Workers' Pneumoconiosis, George Jacobson, H.D. ••••••• • •••• " ••••• II-4 Asbestosis, George Jacobson, M.D •••.••••••••••••••••• II-B A Plastic Step-Block For Testing Film Quality, E. Dale Trout, Sc.D•••• II-ll Good Film Quality For Detecting Pneumoconiosis, E. Nicholas ,Sargent, M.D. II-13 International Classification Of Pneumoconioses, Leonard J. Bristol, M.D. II-17 CARDIOVASCULAR DISEASE IN OCCUPATIONAL MEDICINE Diagnosis Of Coronary Heart Disease, Nicholas DePasquale, M.D. III-I Job Placement And Management Of The Cardiac Patient At Work, Leon J. Warshaw" M.D •••••••.••••.•••••••• 1II-7 Occupational Health Service, Seven Common Problems, E. R. Plunkett, M.D. III-12 Prevention Of Coronary Heart Disease, James A. Schoenberger, M.D •• III-17 CARDIOVASCULAR DEMONSTRATION WORK EVALUATION STRESS TESTING Graded Exercise Testing, I. Martin Grais, M.D. IV-I Exercise Testing In Preventive Medicine, Jean Spencer Felton, M.D. IV-6 Exercise Therapy For Angina, John E. Smith, M.D. IV-13 PAGE MEDICAL MONITORING FOR OCCUPATIONAL DISEASE A New Phase For Occupational Medicine, Irving R. Tabershaw, M.D •••••• V-l How Can Monitoring Be Accomplished? Rita Dingman, R.N., M.P.H. • ••• V-6 Administrative Problems Related To Medical Monitoring, Merle Bundy, M.D •• V-l1 Medical Monitoring And Two New Standards, Miles o. Colwell, M.D ••••• V-l4 MISSED AND MIS-DIAGNOSES IN CHEMICAL EXPOSURES Chemical Exposure, Three Case Histories, Carl U. Dernehl, M.D •• VI-3 Carbon Monoxide And Lead Exposure, Bertram D. Dinman, M.D. VI-6 Occupational Dermatoses, Donald J. Birmingham, M. D•••• VI-9 Noise, Hearing, And Audiometry, Richard A. Nelson, M.D. VI-l4 INDUSTRIAL HYGIENE DEMONSTRATION OF ENVIRONMENTAL MEASUREMENT TECHNIQUES Monitoring The Occupational Environment, General Concepts, Jerome T. Siedlecki, M.S ••••••••' ••••••• VII-l Measurement Of Particulates, Robert Weidner, M.S. VII-5 Measurement Of Gases And Vapors, Julian B. Olishifski, P.E. VII-9 Measurement Of Physical Agents, C. Lyle Cheever, M.D. VII-l2 APPENDIX--INDEX OF SPEAKERS AND MODERATORS • A-l OCCUPATIONAL MEDICINE SYMPOSIA ABSTRACT Through a survey of AMA-member physicians, NIOSH determined the primary occupational medicine problems and information needs of private practitioners with part-time occupational medicine responsibilities. The results of the survey were used to develop the program of the 1974 AMA Congress on Occupational Health, co-sponsored by NIOSH. Papers were presented on the following topics: Occupational pulmonary diseases; chest X-rays for the detection of pneumoconioses; cardiovascular disease in occupational medicine; work evaluation and stress testing; medical monitoring for occupational disease; chemical exposures; noise, hearing, and audiometry, and environmental measurement techniques. The papers presented at the meeting, published by NIOSH, are an introductory text, highlighting the aspects of occupational medicine most significant to part-time plant physicians, to private practitioners generally, and to others with related interests. INTRODUCTION The Occupational Safety and Health Act of 1970 directed the attention of many elements of Ameri­ can society, including the health professions, to the health and safety problems of Americans on the job. In its efforts to promote effective health care for American working men and women, the National Institute for Occupational Safety and Health (NIOSH) has developed programs to assist the assimilation of occupational medicine concepts and skills into general health care delivery. The exact number of physicians who work in occupational medicine is not known, but there are indications that the number of physicians with part-time industrial practice is increasing. Those who seek specialized information often find that appropriate educational opportunities are limited. Accordingly, NIOSH's Division of Occupational Health Programs surveyed 800 AHA member physicians to identify their specific interests in continuing education related to occupational medicine. The physicians surveyed were chosen on the basis of AMA professional records indicating at least some time spent in occupational medicine. Topics which were ranked highest by respondents included occupational pulmonary diseases, cardiovascular diseases, medical minotoring, and tox­ icology. This information has been added to the criteria used by NIOSH in evaluating the direction, impact, and content of occupational health programs. .Specifically, the interests revealed by the 800 part-time occupational health physicians surveyed have led to NIOSH programs designed to promote the exchange of pertinent and practical information for the health practitioner. In one such activity, NIOSH co-sponsored the AMA's 34th Congress on Occupational Health, September 9-10, 1974, Chicago, Illinois. This prestigious annual event is one of the few sources of continuing professional education in occupational medicine available to medical practitioners. The results of the survey were used in developing the scientific program for the Congress in order to include subjects of high priority for prospective attendees, in particular, those with limited occupational medicine training and/or part-time industrial practice. In addition, the Congress was designed as a workshop in order to allow optimum audience partici­ pation and
Load more

Recommended publications
  • Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy
    395 Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy Ferran Morell, MD1,2 Ana Villar, MD2,3 Iñigo Ojanguren, MD2,3 Xavier Muñoz, MD2,3 María-Jesús Cruz, PhD2,3 1 Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Catalonia, Spain Address for correspondence Ferran Morell, MD, Vall d’Hebron Institut 2 Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain de Recerca (VHIR), PasseigValld’Hebron, 119-129, 08035 Barcelona, 3 Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Catalonia, Spain (e-mail: [email protected]). Barcelona, Spain Semin Respir Crit Care Med 2016;37:395–405. Abstract This review presents an update of the currently available information related to Keywords hypersensitivity pneumonitis, with a particular focus on the contribution of several ► hypersensitivity techniques in the diagnosis of this condition. The methods discussed include proper pneumonitis elaboration of a complete medical history, targeted auscultation, detection of specific ► bronchoalveolar immunoglobulin G antibodies against the most common antigens causing this disease, lavage skin tests, antigen-specific lymphocyte activation assays, bronchoalveolar lavage, and ► fi speci c inhalation cryobiopsy. Special emphasis is placed on the relevant contribution of specificinhalation challenge challenge (bronchial challenge test). Surgical lung biopsy is presented as the ultimate ► bronchial challenge recourse, to be used when the diagnosis cannot be reached through the other methods test covered.
    [Show full text]
  • MS32-Chun-Red
    Text19/12/2008 MATERIAL SAFETY DATA SHEET PRODUCT / MATERIAL: GLAZE MANUFACTURER / DISTRIBUTOR: LAGUNA CLAY COMPANY ADDRESS: 14400 Lomitas Avenue, City of Industry, CA 91746 PHONE / FAX / EMAIL: (626) 330-0631 / (626) 333-7694 / [email protected] SECTION I - PRODUCT INFORMATION TRADE NAME: MS32 SYNONYM: CHUN RED CHEMICAL FAMILY: Ceramic Blend SECTION II - HAZARDOUS INGREDIENTS Maximum OSHA PEL NIOSH REL ACGIH TLV INGREDIENT NAMEPercent CAS NUMBER TWA: (mg/m3) TWA: (mg/m3) TWA: (mg/m3) Barium or Barium Compounds5 7440-39-3 0.5 0.5 0.5 Calcium Carbonate7 1317-65-3 5 5 10 Lithium Carbonate1 554-13-2 Silica, Crystalline (Quartz)20 14808-60-7 10 mg/m3 / 0.05 0.05 %SiO2 + 2 Silicon Carbide1 409-21-2 15 10 Tin or Tin Compounds2 7440-31-5 2 2 Zinc or Zinc Compounds4 7440-66-6 5 5 5 SECTION III - PHYSICAL DATA BOILING POINT (°F) Not Applicable VAPOR PRESSURE Not Applicable VAPOR DENSITY Not Applicable SOLUBILITY IN WATER Insoluble SPECIFIC GRAVITY 1.7 – 3.7 PERCENT VOLATILE BY WEIGHT 0 EVAPORATION RATE 0 APPEARANCE AND ODOR Color varies between moist and dry state; no odor. SECTION IV - FIRE AND EXPLOSION HAZARD DATA FLASH POINT Not Flammable EXTINGUISHING MEDIA Water UNUSUAL FIRE OR EXPLOSION HAZARDS None SPECIAL FIRE FIGHTING PROCEDURES None SECTION V - REACTIVITY DATA STABILITY FACTOR Product is stable. INCOMPATIBILITY None HAZARDOUS DECOMPOSITION PRODUCTS None. Hazardous polymerization will not occur. CONDITIONS TO AVOID Inhalation of dust. Text10MS32 Text10Page 1 of 3 Text19/12/2008 MATERIAL SAFETY DATA SHEET SECTION VI - HEALTH HAZARD DATA Barium or Barium Compounds Chronic Toxicity: Chronic overexposure may lead to varying degress of paralysis of the extremities.
    [Show full text]
  • An Approach to Interpreting Restrictive Spirometric Pattern Results In
    Med Lav 2016; 107, 6: 419-436 An approach to interpreting restrictive spirometric pattern results in occupational settings Federica Tafuro, Massimo Corradi Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy KEY WORDS Diagnostic algorithm; FEV1; FVC; FEV6; FEV1/FVC; interpretative criteria; lung function testing; occupa- tional exposure PAROLE CHIAVE Algoritmi diagnostici; FEV1; FVC; FEV6; FEV1/FVC; criteri interpretativi; test di funzionalità polmonare; esposizione occupazionale SUMMARY Objectives: The aim of this review is to provide an updated overview of definition, epidemiology, diagnostic algo- rithm and occupational exposures related to abnormal restrictive spirometrical pattern (RSP) in order to improve the correct interpretation of spirometry test results by occupational healthcare providers. Methods: A review of the scien- tific English literature of the last 25 years was carried out with MEDLINE and related keywords [(restricti* AND spirometr*) AND occupational]. The first step analysis covered 40 studies and the second step the reference list. Results are presented in four major aims and subquestions. Results: A spirometrical pattern of reduced VC (Vital Capacity), together with a normal FEV1 (Forced Expiratory Volume in 1 Second)/VC ratio, is suggestive, though not diagnostic of restrictive ventilatory defect (RVD). The prevalence of RSP is high in some studies, comparable to obstructive pat- tern, and could be associated to chronic medical conditions (diabetes, congestive heart failure, obesity, hypertension) as well as to increased risk of mortality and lung cancer. In order to predict true restrictive defect [TLC-(Total Lung Capacity) <LLN (Lower Limit of Normality) gold-standard for diagnosing restrictive lung diseases (RLD)] from spirometrical data, mathematical models have been developed, but more studies in occupational setting are necessary to clarify the accuracy of such approaches in health surveillance programmes.
    [Show full text]
  • Workers' Compensation for Occupational Respiratory Diseases
    ORIGINAL ARTICLE http://dx.doi.org/10.3346/jkms.2014.29.S.S47 • J Korean Med Sci 2014; 29: S47-51 Workers’ Compensation for Occupational Respiratory Diseases So-young Park,1 Hyoung-Ryoul Kim,2 The respiratory system is one of the most important body systems particularly from the and Jaechul Song3 viewpoint of occupational medicine because it is the major route of occupational exposure. In 2013, there were significant changes in the specific criteria for the recognition of 1Occupational Lung Diseases Institute, Korea Workers’ Compensation & Welfare Service, Ansan; occupational diseases, which were established by the Enforcement Decree of the Industrial 2Department of Occupational and Environmental Accident Compensation Insurance Act (IACIA). In this article, the authors deal with the Medicine, College of Medicine, the Catholic former criteria, implications of the revision, and changes in the specific criteria in Korea by University of Korea, Seoul; 3Department of focusing on the 2013 amendment to the IACIA. Before the 2013 amendment to the IACIA, Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, occupational respiratory disease was not a category because the previous criteria were Korea based on specific hazardous agents and their health effects. Workers as well as clinicians were not familiar with the agent-based criteria. To improve these criteria, a system-based Received: 20 December 2013 structure was added. Through these changes, in the current criteria, 33 types of agents Accepted: 6 April 2014 and 11 types of respiratory diseases are listed under diseases of the respiratory system. In Address for Correspondence: the current criteria, there are no concrete guidelines for evaluating work-relatedness, such Hyoung-Ryoul Kim, MD as estimating the exposure level, latent period, and detailed examination methods.
    [Show full text]
  • Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-Mail
    Central Annals of Clinical Pathology Bringing Excellence in Open Access Review Article *Corresponding author Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road Silicosis: Pathogenesis and Changklan Muang Chiang Mai 50100 Thailand; Tel: 66 53 276364; Fax: 66 53 273590; E-mail: Biomarkers Submitted: 04 October 2018 Accepted: 31 October 2018 1,2 3 Attapon Cheepsattayakorn * and Ruangrong Cheepsattayakorn Published: 31 October 2018 1 10 Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand ISSN: 2373-9282 2 Department of Disease Control, Ministry of Public Health, Thailand Copyright 3 Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand © 2018 Cheepsattayakorn et al. OPEN ACCESS Abstract Ramazzini first described this disease, namely “Pneumonoultramicroscopicsilicovolcanokoniosis” Keywords and then was changed according to the types of exposed dust. No reliable figures on the silica- • Silicosis inhalation exposed individuals are officially documented. How silica particles stimulate pulmonary • Biomarkers response and the exact path physiology of silicosis are still not known and urgently require further • Pathogenesis research. Nevertheless, many researchers hypothesized that pulmonary alveolar macrophages play a major role by secreting fibroblast-stimulating factor and re-ingesting these ingested silica particles by the pulmonary alveolar macrophage with progressive magnification. Finally, ending up of the death of the pulmonary alveolar macrophages and the development of pulmonary fibrosis appear. Various mediators, such as CTGF, FBRS, FGF2/bFGF, and TNFα play a major role in the development of silica-induced pulmonary fibrosis. A hypothesis of silicosis-associated abnormal immunoglobulins has been postulated. In conclusion, novel studies on pathogenesis and biomarkers of silicosis are urgently needed for precise prevention and control of this silently threaten disease of the world.
    [Show full text]
  • Etiology and Aggravation in Thoracic Medicine
    DePaul Law Review Volume 21 Issue 1 Fall 1971: Medico-Legal Symposium II Article 6 Etiology and Aggravation in Thoracic Medicine W. B. Buckingham Follow this and additional works at: https://via.library.depaul.edu/law-review Recommended Citation W. B. Buckingham, Etiology and Aggravation in Thoracic Medicine, 21 DePaul L. Rev. 103 (1971) Available at: https://via.library.depaul.edu/law-review/vol21/iss1/6 This Article is brought to you for free and open access by the College of Law at Via Sapientiae. It has been accepted for inclusion in DePaul Law Review by an authorized editor of Via Sapientiae. For more information, please contact [email protected]. ETIOLOGY AND AGGRAVATION IN THORACIC MEDICINE W. B. BUCKINGHAM* INTRODUCTION N THE practice of thoracic medicine, misconceptions about the etiology and/or the aggravation of thoracic diseases are common- place. These errors are frequently perpetuated by patients and occasionally by well-meaning lawyers and well-trained physicians. Superficial analysis indicates that most of these misconceptions arise from the concept of post hoc ergo propter hoc. In diseases affecting the thorax, multiple etiological factors commonly operate over pro- longed periods of time. Under such circumstances it is extremely difficult to sort out cause and effect. Thus, in light of the imperfec- tions in diagnosis, misconceptions about etiology and aggravation of disease can be appreciated. There are substantial limitations and uncertainties to any medical diagnosis. The semantic derivation of the word "diagnosis" comes through the Greek words whose meaning is "to know through" or "to understand by means of the manifestations of." A complete diagnosis in the modem sense of the term is a disease entity in which the causative mechanisms are clearly understood, and the man- ifestations readily appreciated both in clinical signs and symptoms and in laboratory findings.
    [Show full text]
  • CT Findings of High-Attenuation Pulmonary Abnormalities
    Insights Imaging (2010) 1:287–292 DOI 10.1007/s13244-010-0039-2 PICTORIAL REVIEW CT findings of high-attenuation pulmonary abnormalities Naim Ceylan & Selen Bayraktaroglu & Recep Savaş & Hudaver Alper Received: 5 June 2010 /Revised: 10 July 2010 /Accepted: 16 August 2010 /Published online: 4 September 2010 # European Society of Radiology 2010 Abstract features and radiological findings can significantly improve Objectives To review the computed tomography (CT) diagnostic accuracy. findings of common and uncommon high-attenuation pulmonary lesions and to present a classification scheme Keywords Computed tomography. Pulmonary of the various entities that can result in high-attenuation abnormalities . High attenuation . Nodules . Reticular pulmonary abnormalities based on the pattern and distribu- pattern . Consolidation . Extraparenchymal lesions tion of findings on CT. Background High-attenuation pulmonary abnormalities can result from the deposition of calcium or, less commonly, Introduction other high-attenuation material such as talc, amiodarone, iron, tin, mercury and barium sulphate. CT is highly High-attenuation pulmonary abnormalities can result from a sensitive in the detection of areas of abnormally high variety of different conditions, including from the deposi- attenuation in the lung parenchyma, airways, mediastinum tion of calcium. Amiodarone pulmonary toxicity may cause and pleura. The cause of the calcifications and other high- high-attenuation pulmonary parenchymal opacities. Multi- attenuation conditions may be determined based on the ple dense nodular opacities are rarely seen in siderosis, location and pattern of the abnormalities within the lung stannosis, talcosis and baritosis, in which iron, tin, talc and parenchyma and knowledge of the associated clinical barium sulfate respectively are deposited in the lungs.
    [Show full text]
  • Nebulizers: Diagnosis Codes – Medicare Advantage Policy Appendix
    UnitedHealthcare® Medicare Advantage Policy Appendix: Applicable Code List Nebulizers: Diagnosis Codes This list of codes applies to the Medicare Advantage Policy Guideline titled Approval Date: September 8, 2021 Nebulizers. Applicable Codes The following list(s) of procedure and/or diagnosis codes is provided for reference purposes only and may not be all inclusive. The listing of a code does not imply that the service described by the code is a covered or non-covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply. Diagnosis Code Description For HCPCS Codes A7003, A7004, and E0570 A15.0 Tuberculosis of lung A22.1 Pulmonary anthrax A37.01 Whooping cough due to Bordetella pertussis with pneumonia A37.11 Whooping cough due to Bordetella parapertussis with pneumonia A37.81 Whooping cough due to other Bordetella species with pneumonia A37.91 Whooping cough, unspecified species with pneumonia A48.1 Legionnaires' disease B20 Human immunodeficiency virus [HIV] disease B25.0 Cytomegaloviral pneumonitis B44.0 Invasive pulmonary aspergillosis B59 Pneumocystosis B77.81 Ascariasis pneumonia E84.0 Cystic fibrosis with pulmonary manifestations J09.X1 Influenza due to identified novel influenza A virus with pneumonia J09.X2 Influenza due to identified novel influenza A virus with other
    [Show full text]
  • Toxicological Profile for Barium and Barium Compounds
    TOXICOLOGICAL PROFILE FOR BARIUM AND BARIUM COMPOUNDS U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry August 2007 BARIUM AND BARIUM COMPOUNDS ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. BARIUM AND BARIUM COMPOUNDS iii UPDATE STATEMENT A Toxicological Profile for Barium and Barium Compounds, Draft for Public Comment was released in September 2005. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology and Environmental Medicine/Applied Toxicology Branch 1600 Clifton Road NE Mailstop F-32 Atlanta, Georgia 30333 BARIUM AND BARIUM COMPOUNDS iv This page is intentionally blank. v FOREWORD This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA). The original guidelines were published in the Federal Register on April 17, 1987. Each profile will be revised and republished as necessary. The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for the hazardous substance described therein. Each peer-reviewed profile identifies and reviews the key literature that describes a hazardous substance's toxicologic properties. Other pertinent literature is also presented, but is described in less detail than the key studies. The profile is not intended to be an exhaustive document; however, more comprehensive sources of specialty information are referenced.
    [Show full text]
  • Diapositivo 1
    A.C. Nunes1, A. Domingues1, M. Almeida-Silva1,2, S. Viegas2, C. Viegas2 1 Escola Superior de Tecnologia e Saúde de Lisboa, Instituto Politécnico de Lisboa 2 Instituto Tecnológico e Nuclear, Instituto Superior Técnico, Universidade Técnica de Lisboa. Cork is a light, porous, impermeable material extracted from the bark of some trees. The most widely used cork is obtained from the cork tree Health Effects (Quercus suber). It is estimated that the area occupied by cork oaks in the Iberian Peninsula is around 33% in Portugal and 23% in Spain [1]. The studied articles refer two major diseases associated with this Portugal is the largest cork producing country in the world, followed by occupational setting, occupational asthma and Suberosis. Spain, and its industry is an important economical resource [2].The Occupational asthma is a disease whose origin is related to the processes used in the manufacture of cork depend on the end product to be obtained, being the production of stoppers for wine bottles the exposure to a particular factor in a workplace. Recent studies have main application. Most of the cork is stored under dark humid and identified Chrysonilia sitophila as a cause for this occupational disease moldy conditions. During the manufacturing process, workers are in the cork and logging industry [4, 5]. This fungi is a common mould exposed to an environment that is heavily contaminated with cork dust found in cork samples analyzed [6]. [3]. Due to this repeated exposure to moldy cork dust, cork workers are at risk for developing occupational lung diseases such as occupational Suberosis is the term applied to hypersensitivity pneumonitis due to asthma and Suberosis.
    [Show full text]
  • A ABPA, 69, 71 Acinus-Terminal Respiratory Unit, 8 Acute
    Index A — in microscopic polyangiitis, 143 — asbestosis, 99 ABPA, 69, 71 — p-ANCA, 143, 144, 147, 148 — BOOP, 57, 59 Acinus-terminal respiratory unit, 8 —— in Wegener granulomatosis, 135, 136, 139 — cell profiles, 16 Acute hypersensitive pneumonitis, ground- Anti Scl-70 antibodies, 113, 115 — CEP, 72 glass attenuation, 22 Anti-GBM disease see Goodpasture disease — Crohn disease, 196 Acute interstitial pneumonia (AIP), 4, 37, Anti-GMB antibodies, 135 — CSS, 147, 150 61–63 Anti–GM-CSF autoantibodies, 167 — DIP, 47 — clinical conditions associated, 62 Antimoniosis, 101 — drug-induced lung diseases, 75, 77 — diagnosis procedure, 61, 63 Anti-neutrophil cytoplasmic autoantibodies — hypersensitivity pneumonitis, 95 — histopathological findings, 61, 62 see ANCAs — idiopathic pulmonary fibrosis, 43 — lung lavage cell profiles, 16 Anti-nuclear antibodies (ANA), in SLE, 119, — in IIP diagnosis, 38–39 — pathogenesis, 61 120, 121 — IPF, 43 — symptoms, 61 Antiphospholipid syndrome, 123 — IPH, 159, 162 — therapy, 63 ARDS see acute respiratory distress syndrome — Langerhans cell histiocytosis, 177 Acute lupus pneumonitis, 119 Asbestosis, 97, 99 — LIP, 65 Acute respiratory distress syndrome (ARDS), — malignant mesothelioma with, 201 — NSIP, 52 in pancreatitis, 193, 194 Asthma, heroin-related, 85 — PAM, 163 Acute silicoproteinosis, 97 — PAP, 167, 168, 169 AIP see acute interstitial pneumonia B — RB-ILD, 47, 49 Airway obstruction, interstitial lung disease BAL see bronchoalveolar lavage — rheumatoid arthritis, 110 and, 12, 15 Ball, R., 107 — Sjögren syndrome,
    [Show full text]
  • Bagassosis, Rare Cause of Hypersensitivity Pneumonitis: a Case Report
    IBEROAMERICAN JOURNAL OF MEDICINE 04 (2020) 381-384 Journal homepage: www.iberoamericanjm.tk Case Report Bagassosis, rare cause of hypersensitivity pneumonitis: A case report Tyagi Aruna,*, Jadhav Sagara, Waghmare Manoja, Srivastava AKa, Khare ABa aDepartment of Medicine, DVPPF’s Medical College, Ahmednagar, Maharashtra, PIN-414111, India ARTICLE INFO ABSTRACT Article history: Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a Received 14 May 2020 respiratory syndrome involving the lung parenchyma specifically the alveoli, Received in revised form 18 May terminal bronchioles and alveolar interstitium. HP is caused by delayed allergic 2020 reaction to variety of antigens like microbes, animal proteins, and low-molecular- weight chemicals. Bagassosis is one such HP caused by repetitive inhalation of Accepted 19 May 2020 bagasse. Though use of bagasse as cause of HP is known, use of bagasse in brick- kiln factory as fuel and its association with HP has not been well documented. We Keywords: report a case of HP in a brick-kiln worker where bagasse was used as fuel. Interstitial lung disease A twenty-five years old man, working in a brick kiln for five years, presented with Hypersensitivity pneumonia complaints of dry cough, low grade fever and weight loss for one month. He had Bagassosis bilateral lower lobe crackles on auscultation. The history of bagasse, clay and coal dust exposure, clinical presentation and imaging were suggestive of HP. However, being endemic in India, pulmonary tuberculosis was ruled out by negative Mantoux test, sputum for acid fast bacilli and Cartridge Based Nucleic Acid Amplification Test. He was managed with corticosteroids and symptomatic treatment with good response and resolution of clinical signs and radiological changes.
    [Show full text]